Medeon Biodesign (6499) — Cash Flow Quality Index
Medeon Biodesign (6499) has a Cash Flow Quality Index of 0.90x as of March 2022. Operating cash flow of NT$60.74 Million is below net income of NT$67.17 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore total assets of Medeon Biodesign for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Medeon Biodesign Cash Flow Quality Index (2018–2021)
Historical Cash Flow Quality Index for Medeon Biodesign across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 6499 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Medeon Biodesign (2018–2021)
Year-by-year earnings quality comparison for Medeon Biodesign. For live market cap and the full company financial profile, see market cap of Medeon Biodesign.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -0.14x | NT$-293.38 Million | NT$2.08 Billion | ▼ -111.2% |
| 2018 | 1.26x | NT$322.05 Million | NT$256.60 Million | — |